Clinical Trial: Endoscopic Quality Improvement Program

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: The Effect of an Intensive Endoscopic Quality Improvement Program (EQUIP) on Improved Detection and Classification of Non-polypoid (Flat and Depressed) and Polypoid Colorectal Adenomas. ("EQUIP&q

Brief Summary: Effective colorectal cancer (CRC) screening relies on early identification and removal of both polypoid and non-polypoid lesions with neoplastic potential. The investigators hypothesize that an intensive training program designed to enhance both recognition and classification of lesions with neoplastic potential, will result in an increase in non-polypoid adenoma detection in addition to and independent of an increase in overall adenoma detection rates.

Detailed Summary: Our Endoscopic Quality Improvement Program (EQUIP) was a prospective educational intervention with our staff endoscopist as our study population. The investigators measured adenoma detection rates for a baseline period then randomly assigned half of the endoscopists to undergo EQUIP training. The investigators then examined baseline and post-training study adenoma detection rates (ADR's) for all endoscopist (trained and un-trained) to evaluate the impact of training.
Sponsor: Mayo Clinic

Current Primary Outcome: Measurement of overall adenoma detection rate [ Time Frame: 1 year ]

Primary outcome measures will include overall and per patient adenoma detection rate for polypoid and non polypoid neoplastic lesions.


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Measurement of total polypectomy rate [ Time Frame: 1 Year ]
    Secondary outcomes will include total polypectomy rate (hyperplastic vs. adenoma),
  • Measurement of colonoscopy time [ Time Frame: 1 Year ]
    Total colonoscopy time and endoscopist acceptance. Variables such as patient demographics and prep quality will be adjusted for.
  • Endoscopist Acceptance [ Time Frame: 1 Year ]
    Ensdoscopist acceptance rate will be measured. Variables such as patient demographics and prep quality will be adjusted for.


Original Secondary Outcome: Same as current

Information By: Mayo Clinic

Dates:
Date Received: August 8, 2011
Date Started: August 2010
Date Completion:
Last Updated: August 11, 2011
Last Verified: August 2011